C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend

Immunology Letters

Volumn 169, Issue , 2016, Pages 82-92

  Ermert, David ^a   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Apoptosis; C4b binding protein; Complement; Group A Streptococcus; Protein S

Indexed keywords

AMYLIN; AMYLOID; COMPLEMENT COMPONENT C4B BINDING PROTEIN; PROTEIN S; VIRULENCE FACTOR;

ALPHA CHAIN; APOPTOSIS; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BETA CHAIN; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENT CONTROL PROTEIN DOMAIN; COMPLEMENT INHIBITION; EXPERIMENTAL ANIMAL; GROUP A STREPTOCOCCAL INFECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; NECROSIS; NONHUMAN; PANCREAS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SPONTANEOUS ABORTION; STREPTOCOCCUS PYOGENES; ANIMAL; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; MUTATION; PREGNANCY; PREGNANCY COMPLICATION;

ABORTION, SPONTANEOUS; ANIMALS; ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLEMENT ACTIVATION; COMPLEMENT C4B-BINDING PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMEOSTASIS; HUMANS; MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84949908683     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2015.11.014     Document Type: Review

References (133)

1. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
2. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
3. Merle N.S., Noe R., Halbwachs-Mecarelli L., Fremeaux-Bacchi V., Roumenina L.T. Complement system part II: role in immunity. Front. Immunol. 2015, 6:257.
4. Grumach A.S., Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol. Immunol. 2014, 61:110-117.
5. Zhou X., Hu W., Qin X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist 2008, 13:954-966.
6. Okroj M., Osterborg A., Blom A.M. Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies. Cancer Treat. Rev. 2013, 39:632-639.
7. Merle N.S., Church S.E., Fremeaux-Bacchi V., Roumenina L.T. Complement system part I-molecular mechanisms of activation and regulation. Front. Immunol. 2015, 6:262.
8. Marcovina S.M., Zoppo A., Vigano-D'Angelo S., Di Cola G., D'Angelo A. Determination of serum levels of complement component C4b-binding protein: influence of age and inflammation. Int. J. Clin. Lab. Res. 1991, 21:171-175.
9. Sanchez-Corral P., Criado Garcia O., Rodriguez de Cordoba S. Isoforms of human C4b-binding protein: I. Molecular basis for the C4BP isoform pattern and its variations in human plasma. J. Immunol. 1995, 155:4030-4036.
10. Hillarp A., Dahlback B. Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:1183-1187.
11. Kask L., Hillarp A., Ramesh B., Dahlback B., Blom A.M. Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 2002, 41:9349-9357.
12. Hofmeyer T., Schmelz S., Degiacomi M.T., Dal Peraro M., Daneschdar M., Scrima A., et al. Arranged sevenfold: structural insights into the C-terminal oligomerization domain of human C4b-binding protein. J. Mol. Biol. 2013, 425:1302-1317.
13. Hillarp A., Hessing M., Dahlback B. Protein S binding in relation to the subunit composition of human C4b-binding protein. FEBS Lett. 1989, 259:53-56.
14. Garcia de Frutos P., Alim R.I., Hardig Y., Zoller B., Dahlback B. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994, 84:815-822.
15. Dahlback B., Smith C.A., Muller-Eberhard H.J. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:3461-3465.
16. Hillarp A., Dahlback B. Novel subunit in C4b-binding protein required for protein S binding. J. Biol. Chem. 1988, 263:12759-12764.
17. Dahlback B., Hildebrand B. Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex. Biochem. J. 1983, 209:857-863.
18. Agarwal V., Talens S., Grandits A.M., Blom A.M. A novel interaction between complement inhibitor C4b-binding protein and plasminogen that enhances plasminogen activation. J. Biol. Chem. 2015, 290:18333-18342.
19. Carlsson S., Dahlback B. Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein. J. Biol. Chem. 2010, 285:32038-32046.
20. Chung L.P., Bentley D.R., Reid K.B. Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem. J. 1985, 230:133-141.
21. Criado-Garcia O., Fernaud-Espinosa I., Bovolenta P., Sainz de la Cuesta R., Rodriguez de Cordoba S. Expression of the beta-chain of the complement regulator C4b-binding protein in human ovary. Eur. J. Cell Biol. 1999, 78:657-664.
22. Suankratay C., Mold C., Zhang Y., Lint T.F., Gewurz H. Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins. Clin. Exp. Immunol. 1999, 117:442-448.
23. Fujita T., Gigli I., Nussenzweig V. Human C4-binding protein: II. Role in proteolysis of C4b by C3b-inactivator. J. Exp. Med. 1978, 148:1044-1051.
24. Scharfstein J., Ferreira A., Gigli I., Nussenzweig V. Human C4-binding protein. I. Isolation and characterization. J. Exp. Med. 1978, 148:207-222.
25. Nagasawa S., Ichihara C., Stroud R.M. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator. J. Immunol. 1980, 125:578-582.
26. Daha M.R., van Es L.A. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein. J. Immunol. 1980, 125:2051-2054.
27. Gigli I., Fujita T., Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:6596-6600.
28. Blom A.M., Kask L. Dahlback B. CCP 1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 2003, 39:547-556.
29. Krushkal J., Bat O., Gigli I. Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. Mol. Biol. Evol. 2000, 17:1718-1730.
30. Ferreira A., Takahashi M., Nussenzweig V. Purificaiton and characterization of mouse serum protein with specific binding affinity for C4 (Ss protein). J. Exp. Med. 1977, 146:1001-1008.
31. Kaidoh T., Natsuume-Sakai S., Takahashi M. Murine C4-binding protein: a rapid purification method by affinity chromatography. J. Immunol. 1981, 126:463-467.
32. Kristensen T., Ogata R.T., Chung L.P., Reid K.B., Tack B.F. cDNA structure of murine C4b-binding protein, a regulatory component of the serum complement system. Biochemistry 1987, 26:4668-4674.
33. Ngampasutadol J., Ram S., Blom A.M., Jarva H., Jerse A.E., Lien E., et al. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17142-17147.
34. Oshiumi H., Shida K., Goitsuka R., Kimura Y., Katoh J., Ohba S., et al. Regulator of complement activation (RCA) locus in chicken: identification of chicken RCA gene cluster and functional RCA proteins. J. Immunol. 2005, 175:1724-1734.
35. Oshiumi H., Suzuki Y., Matsumoto M., Seya T. Regulator of complement activation (RCA) gene cluster in Xenopus tropicalis. Immunogenetics 2009, 61:371-384.
36. Jenkins H.T., Mark L., Ball G., Persson J., Lindahl G., Uhrin D., et al. Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor. J. Biol. Chem. 2006, 281:3690-3697.
37. Spencer A.J., Hill F., Honeycutt J.D., Cottingham M.G., Bregu M., Rollier C.S., et al. Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. PLoS One 2012, 7:e33555.
38. Kask L., Villoutreix B.O., Steen M., Ramesh B., Dahlback B., Blom A.M. Structural stability and heat-induced conformational change of two complement inhibitors: C4b-binding protein and factor H. Protein Sci. 2004, 13:1356-1364.
39. Villoutreix B.O., Blom A.M., Webb J., Dahlback B. The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design. Immunopharmacology 1999, 42:121-134.
40. Hardig Y., Hillarp A., Dahlback B. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. Biochem. J. 1997, 323(Pt 2):469-475.
41. Blom A.M., Kask L., Dahlback B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 2001, 276:27136-27144.
42. Ogata R.T., Mathias P., Bradt B.M., Cooper N.R. Murine C4b-binding protein: mapping of the ligand binding site and the N-terminus of the pre-protein. J. Immunol. 1993, 150:2273-2280.
43. Fukui A., Yuasa-Nakagawa T., Murakami Y., Funami K., Kishi N., Matsuda T., et al. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4 bp) by deletion mutagenesis. J. Biochem. 2002, 132:719-728.
44. Leung E., Blom A.M., Clemenza L., Isenman D.E. The complement regulator C4b-binding protein (C4BP) interacts with both the C4c and C4dg subfragments of the parent C4b ligand: evidence for synergy in C4BP subsite binding. Biochemistry 2006, 45:8378-8392.
45. Blom A.M., Webb J., Villoutreix B.O., Dahlback B. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 1999, 274:19237-19245.
46. Blom A.M., Zadura A.F., Villoutreix B.O., Dahlback B. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Mol. Immunol. 2000, 37:445-453.
47. Okroj M., Jenkins H.T., Herbert A.P., Barlow P.N., Blom A.M. Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA. Mol. Immunol. 2008, 46:62-69.
48. Blom A.M., Villoutreix B.O., Dahlback B. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function. J. Biol. Chem. 2003, 278:43437-43442.
49. Blom A.M., Covell D.G., Wallqvist A., Dahlback B. Villoutreix BO. The C4b-binding protein-protein S interaction is hydrophobic in nature. Biochim. Biophys. Acta 1998, 1388:181-189.
50. Webb J.H., Villoutreix B.O., Dahlback B., Blom A.M. Localization of a hydrophobic binding site for anticoagulant protein S on the beta-chain of complement regulator C4b-binding protein. J. Biol. Chem. 2001, 276:4330-4337.
51. Webb J.H., Villoutreix B.O., Dahlback B., Blom A.M. Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies. Eur. J. Biochem. 2003, 270:93-100.
52. Webb J.H., Blom A.M., Dahlback B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J. Immunol. 2002, 169:2580-2586.
53. Trouw L.A., Nilsson S.C., Goncalves I., Landberg G., Blom A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 2005, 201:1937-1948.
54. Anderson H.A., Maylock C.A., Williams J.A., Paweletz C.P., Shu H., Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 2003, 4:87-91.
55. Kask L., Trouw L.A., Dahlback B., Blom A.M. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J. Biol. Chem. 2004, 279:23869-23873.
56. Mihlan M., Blom A.M., Kupreishvili K., Lauer N., Stelzner K., Bergstrom F., et al. Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J. 2011, 25:4198-4210.
57. Braunschweig A., Jozsi M. Human pentraxin 3 binds to the complement regulator c4b-binding protein. PLoS One 2011, 6:e23991.
58. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 1997, 158:4525-4528.
59. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001, 194:781-796.
60. Kuraya M., Ming Z., Liu X., Matsushita M., Fujita T. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology 2005, 209:689-697.
61. Botto M., Walport M.J. C1q, autoimmunity and apoptosis. Immunobiology 2002, 205:395-406.
62. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 2000, 192:359-366.
63. Trouw L.A., Bengtsson A.A., Gelderman K.A., Dahlback B., Sturfelt G., Blom A.M. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 2007, 282:28540-28548.
64. Jones J., Morgan B.P. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 1995, 86:651-660.
65. Olivar R., Luque A., Naranjo-Gomez M., Quer J., Garcia de Frutos P., Borras F.E., et al. The alpha7beta0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells. J. Immunol. 2013, 190:2857-2872.
66. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky G.J., et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990, 39:634-638.
67. Cavaghan M.K., Ehrmann D.A., Polonsky K.S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 2000, 106:329-333.
68. Jurgens C.A., Toukatly M.N., Fligner C.L., Udayasankar J., Subramanian S.L., Zraika S., et al. beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am. J. Pathol. 2011, 178:2632-2640.
69. Sjolander J., Westermark G.T., Renstrom E., Blom A.M. Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation. J. Biol. Chem. 2012, 287:10824-10833.
70. Trouw L.A., Nielsen H.M., Minthon L., Londos E., Landberg G., Veerhuis R., et al. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells. Mol. Immunol. 2008, 45:3649-3660.
71. Sjoberg A.P., Nystrom S., Hammarstrom P., Blom A.M. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. Mol. Immunol. 2008, 45:3213-3221.
72. Sjoberg A.P., Trouw L.A., McGrath F.D., Hack C.E., Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein. J. Immunol. 2006, 176:7612-7620.
73. Happonen K.E., Sjoberg A.P., Morgelin M., Heinegard D., Blom A.M. Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix. J. Immunol. 2009, 182:1518-1525.
74. Coulthard L.G., Woodruff T.M. Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth. J. Immunol. 2015, 194:3542-3548.
75. Blom A.M., Bergstrom F., Edey M., Diaz-Torres M., Kavanagh D., Lampe A., et al. A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity. J. Immunol. 2008, 180:6385-6391.
76. Nester C.M., Barbour T., de Cordoba S.R., Dragon-Durey M.A., Fremeaux-Bacchi V., Goodship T.H., et al. Atypical aHUS: state of the art. Mol. Immunol. 2015, 67:31-42.
77. Martinez-Barricarte R., Goicoechea de Jorge E., Montes T., Layana A.G., Rodriguez de Cordoba S. Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population. Clin. Exp. Immunol. 2009, 155:59-64.
78. Mohlin F.C., Mercier E., Fremeaux-Bacchi V., Liszewski M.K., Atkinson J.P., Gris J.C., et al. Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss. Eur. J. Immunol. 2013, 43:1617-1629.
79. Tincani A., Cavazzana I., Ziglioli T., Lojacono A., De Angelis V., Meroni P. Complement activation and pregnancy failure. Clin. Rev. Allergy Immunol. 2010, 39:153-159.
80. Nonaka M.I., Zsigmond E., Kudo A., Kawakami H., Yoshida K., Yoshida M., et al. Epididymal C4b-binding protein is processed and degraded during transit through the duct and is not essential for fertility. Immunobiology 2015, 220:467-475.
81. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
82. Agarwal V., Hammerschmidt S., Malm S., Bergmann S., Riesbeck K., Blom A.M. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J. Immunol. 2012, 189:3575-3584.
83. Dieudonne-Vatran A., Krentz S., Blom A.M., Meri S., Henriques-Normark B., Riesbeck K., et al. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J. Immunol. 2009, 182:7865-7877.
84. Thern A., Stenberg L., Dahlback B., Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 1995, 154:375-386.
85. Accardo P., Sanchez-Corral P., Criado O., Garcia E., Rodriguez de Cordoba S. Binding of human complement component C4b-binding protein (C4BP) to Streptococcus pyogenes involves the C4b-binding site. J. Immunol. 1996, 157:4935-4939.
86. Ermert D., Shaughnessy J., Joeris T., Kaplan J., Pang C.J., Kurt-Jones E.A., et al. Virulence of group A Streptococci is enhanced by human complement inhibitors. PLoS Pathog. 2015, 11:e1005043.
87. Carlsson F., Berggard K., Stalhammar-Carlemalm M., Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 2003, 198:1057-1068.
88. Ermert D., Weckel A., Agarwal V., Frick I.M., Bjorck L., Blom A.M. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells. J. Biol. Chem. 2013, 288:32172-32183.
89. Berggard K., Lindahl G., Dahlback B., Blom A.M. Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur. J. Immunol. 2001, 31:2771-2780.
90. Pietikainen J., Meri T., Blom A.M., Meri S. Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol. Immunol. 2010, 47:1299-1305.
91. Wooster D.G., Maruvada R., Blom A.M., Prasadarao N.V. Logarithmic phase Escherichia coli K1 efficiently avoids serum killing by promoting C4bp-mediated C3b and C4b degradation. Immunology 2006, 117:482-493.
92. Prasadarao N.V., Blom A.M., Villoutreix B.O., Linsangan L.C. A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of E. coli K1. J. Immunol. 2002, 169:6352-6360.
93. Hallstrom T., Jarva H., Riesbeck K., Blom A.M. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 2007, 178:6359-6366.
94. Nordstrom T., Blom A.M., Forsgren A., Riesbeck K. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J. Immunol. 2004, 173:4598-4606.
95. Ram S., Cullinane M., Blom A.M., Gulati S., McQuillen D.P., Monks B.G., et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J. Exp. Med. 2001, 193:281-295.
96. Jarva H., Ngampasutadol J., Ram S., Rice P.A., Villoutreix B.O., Blom A.M. Molecular characterization of the interaction between porins of Neisseria gonorrhoeae and C4b-binding protein. J. Immunol. 2007, 179:540-547.
97. Blom A.M., Rytkonen A., Vasquez P., Lindahl G., Dahlback B., Jonsson A.B. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein. J. Immunol. 2001, 166:6764-6770.
98. Jarva H., Ram S., Vogel U., Blom A.M., Meri S. Binding of the complement inhibitor C4 bp to serogroup B Neisseria meningitidis. J. Immunol. 2005, 174:6299-6307.
99. Potempa M., Potempa J., Okroj M., Popadiak K., Eick S., Nguyen K.A., et al. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J. Immunol. 2008, 181:5537-5544.
100. Malm S., Jusko M., Eick S., Potempa J., Riesbeck K., Blom A.M. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS One 2012, 7:e34852.
101. Ho D.K., Tissari J., Jarvinen H.M., Blom A.M., Meri S., Jarva H. Functional recruitment of human complement inhibitor C4B-binding protein to outer membrane protein Rck of Salmonella. PLoS One 2011, 6:e27546.
102. Ho D.K., Riva R., Kirjavainen V., Jarva H., Ginstrom E., Blom A.M., et al. Functional recruitment of the human complement inhibitor C4BP to Yersinia pseudotuberculosis outer membrane protein Ail. J. Immunol. 2012, 188:4450-4459.
103. Kirjavainen V., Jarva H., Biedzka-Sarek M., Blom A.M., Skurnik M., Meri S. Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog. 2008, 4:e1000140.
104. Ho D.K., Skurnik M., Blom A.M., Meri S. Yersinia pestis Ail recruitment of C4b-binding protein leads to factor I-mediated inactivation of covalently and noncovalently bound C4b. Eur. J. Immunol. 2014, 44:742-751.
105. Shayakhmetov D.M., Gaggar A., Ni S., Li Z.Y., Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J. Virol. 2005, 79:7478-7491.
106. Avirutnan P., Hauhart R.E., Somnuke P., Blom A.M., Diamond M.S., Atkinson J.P. Binding of Flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J. Immunol. 2011, 187:424-433.
107. Luo S., Blom A.M., Rupp S., Hipler U.C., Hube B., Skerka C., et al. The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J. Biol. Chem. 2011, 286:8021-8029.
108. Meri T., Blom A.M., Hartmann A., Lenk D., Meri S., Zipfel P.F. The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect. Immun. 2004, 72:6633-6641.
109. Vogl G., Lesiak I., Jensen D.B., Perkhofer S., Eck R., Speth C., et al. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol. Immunol. 2008, 45:1485-1493.
110. Andre I., Persson J., Blom A.M., Nilsson H., Drakenberg T., Lindahl G., et al. Streptococcal M protein: structural studies of the hypervariable region, free and bound to human C4BP. Biochemistry 2006, 45:4559-4568.
111. Blom A.M., Berggard K., Webb J.H., Lindahl G., Villoutreix B.O., Dahlback B. Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J. Immunol. 2000, 164:5328-5336.
112. Persson J., Beall B., Linse S., Lindahl G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog. 2006, 2:e47.
113. Johnsson E., Thern A., Dahlback B., Heden L.O., Wikstrom M., Lindahl G. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J. Immunol. 1996, 157:3021-3029.
114. Morfeldt E., Berggard K., Persson J., Drakenberg T., Johnsson E., Lindahl E., et al. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J. Immunol. 2001, 167:3870-3877.
115. Akesson P., Cooney J., Kishimoto F., Bjorck L. Protein H-a novel IgG binding bacterial protein. Mol. Immunol. 1990, 27:523-531.
116. Spijkers P.P., Denis C.V., Blom A.M., Lenting P.J. Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein. Eur. J. Immunol. 2008, 38:809-817.
117. Barthel D., Schindler S., Zipfel P.F. Plasminogen is a complement inhibitor. J. Biol. Chem. 2012, 287:18831-18842.
118. Fulde M., Steinert M., Bergmann S. Interaction of streptococcal plasminogen binding proteins with the host fibrinolytic system. Front. Cell. Infect. Microbiol. 2013, 3:85.
119. Blom A.M., Nandakumar K.S., Holmdahl R. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Ann. Rheum. Dis. 2009, 68:136-142.
120. Beernink P.T., Shaughnessy J., Braga E.M., Liu Q., Rice P.A., Ram S., et al. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J. Immunol. 2011, 186:3606-3614.
121. Dahlback B., Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:2512-2516.
122. Takahashi S., Takahashi M., Kaidoh T., Natsuume-Sakai S., Takahashi T. Genetic mapping of mouse C4-bp locus to the H-2D-Qa interval. J. Immunol. 1984, 132:6-8.
123. Hillarp A., Wiklund H., Thern A., Dahlback B. Molecular cloning of rat C4b binding protein alpha- and beta-chains: structural and functional relationships among human, bovine, rabbit, mouse, and rat proteins. J. Immunol. 1997, 158:1315-1323.
124. He X., Dahlback B. Rabbit plasma, unlike its human counterpart, contains no complex between protein S and C4b-binding protein. Thromb. Haemost. 1994, 71:446-451.
125. Hillarp A., Thern A., Dahlback B. Bovine C4b binding protein: molecular cloning of the alpha- and beta-chains provides structural background for lack of complex formation with protein S. J. Immunol. 1994, 153:4190-4199.
126. Burge J., Nicholson-Weller A., Austen K.F. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase. J. Immunol. 1981, 126:232-235.
127. Grosskinsky S., Schott M., Brenner C., Cutler S.J., Simon M.M., Wallich R. Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl. Trop. Dis. 2010, 4:e698.
128. Tseng Y.T., Wang S.W., Kim K.S., Wang Y.H., Yao Y., Chen C.C., et al. NlpI facilitates deposition of C4 bp on E. coli by blocking classical complement-mediated killing, which results in high-level bacteremia. Infect Immun 2012, 80:3669-3678.
129. Castiblanco-Valencia M.M., Fraga T.R., Silva L.B., Monaris D., Abreu P.A., Strobel S., et al. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J. Infect. Dis. 2012, 205:995-1004.
130. Breda L.C., Hsieh C.L., Castiblanco Valencia M.M., da Silva L.B., Barbosa A.S., Blom A.M., et al. Fine Mapping of the Interaction between C4b-binding protein and outer membrane proteins LigA and LigB of pathogenic Leptospira interrogans. PLoS Negl. Trop. Dis. 2015, 9:e0004192.
131. Barbosa A.S., Monaris D., Silva L.B., Morais Z.M., Vasconcellos S.A., Cianciarullo A.M., et al. Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect. Immun. 2010, 78:3207-3216.
132. Souza N.M., Vieira M.L., Alves I.J., de Morais Z.M., Vasconcellos S.A., Nascimento A.L. Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4 bp. Microb. Pathog. 2012, 53:125-134.
133. Hair P.S., Foley C.K., Krishna N.K., Nyalwidhe J.O., Geoghegan J.A., Foster T.J., et al. Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing. Results Immunol. 2013, 3:114-121.